Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Benjamin Philip Levy, MD, offers opinion on testing for PD-L1 expression in NSCLC

Dr. Levy elaborates on whether every non-small cell lung cancer (NSCLC) patient should be tested for PD-L1 expression and what levels of PD-L1 expression are actionable

Published: 27 June 2018

Recent Videos

video

Andrew Pecora, MD, shares his thoughts on the necessity of allogeneic transplants to MML patients

Dr. Pecora, Chief Innovation Officer, Professor and Vice President of Cancer Services John Theurer Cancer Center, shares his thoughts on ...

video

Nizar Bahlis, MD, speculates on the future of anti-BCMA CAR-T cell therapy in MM

Dr. Bahlis, University of Calgary, Calgary, provides opinion on whether anti-BCMA CAR-T cell therapy looks promising as a treatment option ...

video

Nizar Bahlis, MD, describes current maintenance regimens for multiple myeloma

Dr. Bahlis, University of Calgary, Calgary, discusses current maintenance regimens for multiple myeloma (MM) and how they may change as ...

video

John Burke, MD, elaborates on the Beat AML umbrella study

Dr. Burke, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, tells us about ...

video

Nizar Bahlis, MD, discusses the outcomes of the TOURMALINE-MM3 study from ASH 2018

Dr. Bahlis, University of Calgary, Calgary, tells us how the outcomes of the TOURMALINE-MM3 study may change the way he ...

video

John Burke, MD, comments on clinical research examining gilteritinib in newly diagnosed AML

Dr. Burke, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, comments on the ...

video

Nizar Bahlis, MD, regarding the impact of the POLLUX and CASTOR studies from ASH 2018

Dr. Bahlis, University of Calgary, Calgary, shares how the POLLUX and CASTOR studies presented at the 2018 ASH Annual Meeting ...

video

John Burke, MD, elaborates on the incorporation of venetoclax into AML treatment regimens

Dr. Burke, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, explains how he ...

video

Elizabeth Budde, MD, evaluates the clinical study investigating mosunetuzumab from ASH 2018

Dr. Budde, Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, tells us about the ...

video

John Burke, MD, speaks to the reliability of the FLT3 mutation test

Dr. Burke, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, considers whether the ...

Related Videos

video-image

Nizar Bahlis, MD, describes current maintenance regimens for multiple myeloma

video-image

Elizabeth Budde, MD, discusses the role of CAR-T therapies in lymphoma treatment algorithms

video-image

Nizar Bahlis, MD, speculates on the future of anti-BCMA CAR-T cell therapy in MM

video-image

John Burke, MD, regarding gilteritinib in acute myeloid leukemia treatment

video-image

Andrew Pecora, MD, shares his thoughts on the necessity of allogeneic transplants to MML patients

video-image

Elizabeth Budde, MD, on how City of Hope has overcome logistical hurdles associated with CAR-T

video-image

John Burke, MD, speaks to the reliability of the FLT3 mutation test

video-image

Elizabeth Budde, MD, evaluates the clinical study investigating mosunetuzumab from ASH 2018

video-image

John Burke, MD, elaborates on the incorporation of venetoclax into AML treatment regimens

video-image

Nizar Bahlis, MD, regarding the impact of the POLLUX and CASTOR studies from ASH 2018

video-image

Nikhil Munshi, MD, explains how the ID2 function impacts oncogenesis in multiple myeloma

video-image

John Burke, MD, comments on clinical research examining gilteritinib in newly diagnosed AML

video-image

Nikhil Munshi, MD, tells us about the outcomes of the CA204-142 study investigating elotuzimab

video-image

Nizar Bahlis, MD, discusses the outcomes of the TOURMALINE-MM3 study from ASH 2018

video-image

Nikhil Munshi, MD, discusses the POLLUX and CASTOR studies regarding the use of daratumumab in MM

video-image

John Burke, MD, elaborates on the Beat AML umbrella study

video-image

Nikhil Munshi, MD, discusses the outcomes of the TOURMALINE-MM3 study in multiple myeloma

video-image

Samer Khaled, MD, tells us about the MEDALIST study examining myelodysplastic syndrome

video-image

Ravi Vij, MD, on molecular testing and acute myelogenous leukemia

video-image

Robert Rifkin, MD, talks about what clinical data could change the way multiple myeloma is treated